Literature DB >> 9863014

TGFbeta-induced growth inhibition involves cell cycle inhibitor p21 and pRb independent from p15 expression.

M Voss1, B Wolff, N Savitskaia, H Ungefroren, W Deppert, W Schmiegel, H Kalthoff, M Naumann.   

Abstract

It is generally assumed that TGFbeta induces cell cycle arrest through the cooperative action of cell cycle inhibitors p15, p27 and p21. Here, we found that several pancreatic carcinoma cell lines exert TGFbeta-induced negative growth control in spite of the loss of p15 and p16 expression. In these cell lines, TGFbeta-induced growth control correlates with the upregulation of the p21 protein and active pRb expression. Conversely, cells without p21 and/or pRb expression are resistant to TGFbeta -induced growth inhibition. Moreover, overexpression of p21 in the p21-deficient cell line Panc Tu1 leads to growth arrest. Thus, TGFbeta-induced growth control correlates with p21 expression and pRb status independent of p15 and/or p16 expression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9863014     DOI: 10.3892/ijo.14.1.93

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  9 in total

1.  SCF(beta-TrCP1) controls Smad4 protein stability in pancreatic cancer cells.

Authors:  Mei Wan; Jin Huang; Nirag C Jhala; Ewan M Tytler; Lei Yang; Selwyn M Vickers; Yi Tang; Chongyuan Lu; Ning Wang; Xu Cao
Journal:  Am J Pathol       Date:  2005-05       Impact factor: 4.307

2.  Overexpression of FOXG1 contributes to TGF-beta resistance through inhibition of p21WAF1/CIP1 expression in ovarian cancer.

Authors:  D W Chan; V W S Liu; R M Y To; P M Chiu; W Y W Lee; K M Yao; A N Y Cheung; H Y S Ngan
Journal:  Br J Cancer       Date:  2009-09-15       Impact factor: 7.640

3.  Autocrine growth inhibition by transforming growth factor beta-1 (TGFbeta-1) in human neuroendocrine tumour cells.

Authors:  A Wimmel; B Wiedenmann; S Rosewicz
Journal:  Gut       Date:  2003-09       Impact factor: 23.059

4.  TGFβ1 Cell Cycle Arrest Is Mediated by Inhibition of MCM Assembly in Rb-Deficient Conditions.

Authors:  Brook S Nepon-Sixt; Mark G Alexandrow
Journal:  Mol Cancer Res       Date:  2018-09-26       Impact factor: 5.852

5.  Differential roles of Smad2 and Smad3 in the regulation of TGF-β1-mediated growth inhibition and cell migration in pancreatic ductal adenocarcinoma cells: control by Rac1.

Authors:  Hendrik Ungefroren; Stephanie Groth; Susanne Sebens; Hendrik Lehnert; Frank Gieseler; Fred Fändrich
Journal:  Mol Cancer       Date:  2011-05-30       Impact factor: 27.401

Review 6.  Apoptosis: targets in pancreatic cancer.

Authors:  Sabine Westphal; Holger Kalthoff
Journal:  Mol Cancer       Date:  2003-01-07       Impact factor: 27.401

7.  TGFβ engages MEK/ERK to differentially regulate benign and malignant pancreas cell function.

Authors:  D R Principe; A M Diaz; C Torres; R J Mangan; B DeCant; R McKinney; M-S Tsao; A Lowy; H G Munshi; B Jung; P J Grippo
Journal:  Oncogene       Date:  2017-04-03       Impact factor: 9.867

8.  TGFbeta1 signaling via alphaVbeta6 integrin.

Authors:  Martin P Kracklauer; Christian Schmidt; Guido M Sclabas
Journal:  Mol Cancer       Date:  2003-08-07       Impact factor: 27.401

9.  Treg/Th17 cell balance and phytohaemagglutinin activation of T lymphocytes in peripheral blood of systemic sclerosis patients.

Authors:  Ekaterina Krasimirova; Tsvetelina Velikova; Ekaterina Ivanova-Todorova; Kalina Tumangelova-Yuzeir; Desislava Kalinova; Vladimira Boyadzhieva; Nikolay Stoilov; Tsvetelina Yoneva; Rasho Rashkov; Dobroslav Kyurkchiev
Journal:  World J Exp Med       Date:  2017-08-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.